Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004–2013): Amassing data from independent Western populations provide etiologic clues
- 1 November 2017
- journal article
- conference paper
- Published by Elsevier in European Journal of Cancer
- Vol. 86, 326-333
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention Fellowship Program of the Division of Cancer Prevention
- Intramural Research Program of the National Cancer Institute at the National Institutes of Health
- Intramural Research Program of the National Institutes of Health and National Cancer Institute
This publication has 30 references indexed in Scilit:
- Anticipating the “Silver Tsunami”: Prevalence Trajectories and Co-Morbidity Burden among Older Cancer Survivors in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2016
- Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participantsThe Lancet, 2016
- Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysisAnnals of Oncology, 2015
- International Variation in Female Breast Cancer Incidence and Mortality RatesCancer Epidemiology, Biomarkers & Prevention, 2015
- Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer ObservatoryEuropean Journal of Cancer, 2015
- How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?JNCI: Journal of the National Cancer Institute, 2014
- Tracking and Evaluating Molecular Tumor Markers With Cancer Registry Data: HER2 and Breast CancerJNCI: Journal of the National Cancer Institute, 2014
- Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in DenmarkInternational Journal of Cancer, 2013
- Incidence of Breast Cancer in the United States: Current and Future TrendsJNCI: Journal of the National Cancer Institute, 2011
- Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapyEuropean Journal of Cancer, 2010